Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novo-Nordisk A/S

71.70
+0.97001.37%
Post-market: 71.750.0500+0.07%19:59 EDT
Volume:7.35M
Turnover:524.18M
Market Cap:318.28B
PE:21.08
High:71.80
Open:71.02
Low:70.58
Close:70.73
Loading ...

Goldman Sachs Sticks to Their Buy Rating for Novo Nordisk (0QIU)

TIPRANKS
·
01 Jul

Novo Nordisk A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
01 Jul

Novo Nordisk’s Bold Step in Tackling Childhood Obesity: A New Study Initiative

TIPRANKS
·
28 Jun

Novo Nordisk’s Promising Sickle Cell Study: A Potential Game-Changer?

TIPRANKS
·
28 Jun

Hims & Hers Stock Tumbles as Novo Nordisk Ends Its Wegovy Sales Deal. Can the Telehealth Giant Recover?

Motley Fool
·
27 Jun

Novo Nordisk A/S Stock Falls Thursday, Underperforms Market

Dow Jones
·
27 Jun

Novo Nordisk Stock (NVO) Inches Higher Despite More U.K. Weight Jab Concerns

TIPRANKS
·
26 Jun

Novo Nordisk announces WeightWatchers collaboration for Wegovy

TIPRANKS
·
26 Jun

Morgan Stanley Reaffirms Their Hold Rating on Novo Nordisk (0QIU)

TIPRANKS
·
26 Jun

Stock Track | Novo Nordisk Plummets 5.03% as Spanish Health Ministry Investigates Weight-Loss Drug Advertising

Stock Track
·
26 Jun

Novo Nordisk’s Semaglutide Study: A Potential Breakthrough for Alzheimer’s?

TIPRANKS
·
26 Jun

Novo Nordisk’s ZEUS Study: A Potential Game Changer in Cardiovascular Treatment

TIPRANKS
·
26 Jun

Sector Update: Health Care Stocks Mixed Premarket Wednesday

MT Newswires Live
·
25 Jun

Citi sees tiered orforglipron pricing $15B opportunity for Eli Lilly

TIPRANKS
·
25 Jun

Novo Nordisk Faces Spanish Probe Over Weight-Loss Advertising

Bloomberg
·
25 Jun

After key conference, here's how the race to a $150 billion weight-loss drug market is shaping up

Dow Jones
·
25 Jun

Hims "Won't Cave" to Novo Demands Over Copycat Weight-Loss Shots, CEO Says

Bloomberg
·
25 Jun

Novo Resources Announces AGM Approval and Strategic Updates

TIPRANKS
·
24 Jun

California seeks to cut Medicaid coverage for weight loss drugs, Bloomberg says

TIPRANKS
·
24 Jun

Deutsche Bank Keeps Their Buy Rating on Novo Nordisk (0QIU)

TIPRANKS
·
24 Jun